Answers are grounded in this paper and cite their sources.
Genomics methodologies have advanced to the extent that it is now possible to interrogate the gene expression in a single cell but proteomics has traditionally lagged behind and required much greater cellular input and was not quantitative.Coupling protein with gene expression data is essential for understanding how cell behavior is regulated.Advances primarily in mass spectrometry have, however, greatly improved the sensitivity of proteomics methods over the last decade and the outcome of proteomic analyses can now also be quantified.Nevertheless, it is still difficult to obtain sufficient tissue from staged mammalian embryos to combine proteomic and genomic analyses.Recent developments in pluripotent stem cell biology have in part addressed this issue by providing surrogate scalable cell systems in which early developmental events can be modeled.Here we present an overview of current proteomics methodologies and the kind of information this can provide on the biology of human and mouse pluripotent stem cells.Outline 1 Why study proteomics in stem cells and development?2 Stem cells and developmental potency 3 What are pluripotent stem cells? 4 Aims of this article 5 Proteomic approaches: Contemporary methodologies applicable to stem cell biology 6 Challenges in charting proteomes 7 Phosphoproteomics and analysis of other PTMs 8 Quantitative proteomics 9 Proteome biology of stem cells 10 Future perspectives
No takes yet. Share an insight, caveat, or question.
Hoof et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: